Skip to main content

Cushing's Syndrome (CS) - Market Insights, Epidemiology and Market Forecast

New Delhi, India -- (SBWIRE) -- 08/23/2018 -- Cushing's syndrome, also known as hypercortisolism is an endocrine disorder that occurs due to abnormally high levels of the hormone cortisol production in the body. There are two types of Cushing's syndrome:-
i. Exogenous Cushing's Syndrome- This type of Cushing's syndrome occurs due to excessive use of medications like glucocorticosteroids.
ii. Endogenous Cushing's Syndrome- Endogenous Cushing's syndrome occurs due to over production of cortisol by body as a result of many underlying conditions like stress, anxiety, tumours in adrenal glands, etc. About 80-85% of Cushing Syndrome is Endogenous Cushing's syndrome.

According to the report of DelveInsight "Cushing's Syndrome (CS) - Market Insights, Epidemiology and Market Forecast – 2027" United States accounts for the highest number of cases of Cushing's syndrome. A total of 20,110 prevalent cases were diagnosed in 2015. The total number of Cushing's syndrome cases is expected to reach 20,841 in 2023. Due to decline in the population in 2011, there is a marginal decline in the total Cushing's syndrome patients. Cushing's syndrome in Germany accounts total of 5,346 prevalent cases in 2015. A sudden decrease in the Cushing's syndrome cases from 2010 to 2011 and then a sudden increase in cases from 2011 to 2012 were observed which can be attributed to the fluctuations in population of Germany during those two years. The total number of Cushing's syndrome cases is expected to reach 5,454 in 2023.
Cushing's Syndrome in France accounts total of 2,647 prevalent cases were diagnosed in 2015. The total number of Cushing's Syndrome cases is expected to reach 2,740 in 2023. Cushing's Syndrome in UK accounts total of 4,202 prevalent cases that were diagnosed in 2015. A surge in the number of cases for Cushing's syndrome has been observed from 2011 to 2012 as there was sudden increase in the population of the United Kingdom. The total number of Cushing's syndrome cases is expected to reach 4,412 in 2023. Cushing's Syndrome in Spain accounts total of 2,122 prevalent cases that were diagnosed in 2015. The total number of Cushing's Syndrome cases is expected to reach 2,165 in 2023. Cushing's Syndrome in Italy accounts total of 2,743 prevalent cases that were diagnosed in 2015. A sudden increase in the number of cases for Cushing's syndrome has been observed from 2013 to 2014 as there was sudden increase in the population of Italy. The total number of Cushing's syndrome cases is expected to reach 2,816 in 2023. Cushing's Syndrome cases in Japan accounts total of 3,228 prevalent cases that were diagnosed in 2015. The total number of Cushing's Syndrome cases is expected to reach 3,254 in 2023.

The report provides an overview of the disease and global market trends of the Cushing's Syndrome and will help in developing business strategies by understanding the trends shaping and driving the global Cushing's syndrome market. It organizes sales and marketing efforts by identifying the best opportunities for Cushing's syndrome in 7MM
1. US,
2. European Union 5 (EU5- Germany, Spain, Italy, France and United Kingdom) and
3. Japan.

It helps to understand the future market competition in the global Cushing's syndrome market and Insightful review of the key market drivers and barriers and the regulatory scenario in major markets. The report also covers the detailed global historical and forecasted Cushing's Syndrome market covering United States, European Union 5 (EU5- Germany, Spain, Italy, France and United Kingdom) and Japan from 2013-2027.

For sample pages:https://www.delveinsight.com/search-result.php?term=Cushing%27s+Syndrome-+Market+Insight%2C+Epidemiology+and+Market+Forecast+-+2027&searchcat=&advsearch=

Reasons to buy:

1. The report will help in developing business strategies by understanding trends shaping and driving the Cushing's Syndrome market.
2. To understand the future market competition in the Cushing's Syndrome market and Insight reviews of the key market drivers and barriers.
3. Identification of strong upcoming players in the Cushing's Syndrome market will help in devising strategies that will help in getting ahead of competitors.
4. In-depth understanding of the pipeline development and recent happenings will provide a competitive edge over competitors.

Companies Covered:
1. Corcept Therapeutics
2. Novartis Pharma K.K.
3. Astorg
4. Novartis
And many others……………

Table of Contents

1. Report Introduction
2. Cushing's Syndrome Market Overview at a Glance
3. Disease Background and Overview: Cushing's SyndromeA
4. Epidemiology and Patient Population
5. Epidemiology of Cushing's SyndromeA by Countries
5.1. United States
5.2. EU5
5.3. Assumptions and Rationale
5.4. Germany
5.5. France
5.6. Italy
5.7. Spain
5.8. United Kingdom
5.9. Japan
6. Current Treatment & Medical practices
7. Unmet Needs of the Cushing's Syndrome
8. Marketed Therapies
8.1. Drug A: Company 1
8.2. Drug B: Company 2
9. Pipeline Therapies– At a glance
10. Key Cross Competition
11. Emerging Therapies for Cushing's Syndrome
11.1. Drug C: Company 3
11.2. Drug D: Company 4
12. Cushing's SyndromeA : 7MM Market Analysis
13. Cushing's SyndromeA : Country-Wise Market Analysis
13.1. United States
13.2. EU-5
13.3. Japan
14. Market Drivers
15. Market Barriers
16. Appendix
17. Report Methodology
18. DelveInsight Capabilities
19. Disclaimer
*** For detailed TOC request for sample pages.***

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research Firm focused exclusively on life sciences. We support companies by providing end to end comprehensive solutions to improve their performance and in making long lasting decision for their businesses

We advise leading decision makers on their critical issues and opportunities; Research & Development, Strategy Making, Commercial, Operations, Competitive Intelligence, Competitive Landscaping and Mergers & Acquisition across all the Pharma and Biotech industries and geographies. We serve our clients by delivering practical and enduring results, and equipping our clients to grow and lead.

For more information on this press release visit: http://www.sbwire.com/press-releases/cushing-syndrome-cs-market-insights-epidemiology-market-1034012.htm

Media Relations Contact

ANKIT NIGAM
DELVEINSIGHT
Telephone: 9650213330
Email: Click to Email ANKIT NIGAM
Web: https://www.delveinsight.com/

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.